ACUTE T CELL LEUKEMIA LYMPHOMA

Clinical trials for ACUTE T CELL LEUKEMIA LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new ACUTE T CELL LEUKEMIA LYMPHOMA trials appear

Sign up with your email to follow new studies for ACUTE T CELL LEUKEMIA LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope for tough cancers: experimental drug targets treatment resistance

Disease control Ongoing

This study is testing a new drug called 9-ING-41, which is designed to block a protein that helps cancer cells survive and resist chemotherapy. It is for adults with advanced or metastatic cancers, including pancreatic, breast, and lung cancers, that have worsened despite standar…

Matched conditions: ACUTE T CELL LEUKEMIA LYMPHOMA

Phase: PHASE2 • Sponsor: Actuate Therapeutics Inc. • Aim: Disease control

Last updated Apr 17, 2026 16:10 UTC

ACUTE T CELL LEUKEMIA LYMPHOMA

Get alerted when new ACUTE T CELL LEUKEMIA LYMPHOMA trials appear

New hope for tough cancers: experimental drug targets treatment resistance